Published in J Natl Cancer Inst on December 18, 1996
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol (2014) 2.55
Does tumour dormancy offer a therapeutic target? Nat Rev Cancer (2010) 2.19
Five years of tamoxifen--or more? J Natl Cancer Inst (1996) 1.53
Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (1998) 1.36
Luminal breast cancer: from biology to treatment. Nat Rev Clin Oncol (2013) 1.16
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocr Relat Cancer (2013) 1.11
Status of adjuvant endocrine therapy for breast cancer. Breast Cancer Res (2014) 1.07
Adjuvant tamoxifen: how long before we know how long? BMJ (1998) 0.90
Adjuvant endocrine therapy for premenopausal women with breast cancer. Breast (2009) 0.85
Clinical utility of exemestane in the treatment of breast cancer. Int J Womens Health (2015) 0.79
Extended adjuvant tamoxifen for early breast cancer: a meta-analysis. PLoS One (2014) 0.78
Update on the use of aromatase inhibitors in early-stage breast cancer. Breast Cancer Res (2009) 0.77
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives. Pharmgenomics Pers Med (2016) 0.76
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer. BMC Cancer (2016) 0.75
Visible humans give doctors a stage for surgical rehearsals. J Natl Cancer Inst (1996) 0.75
Recent advances in adjuvant systemic treatment for breast cancer: all systems go! Curr Oncol (2006) 0.75
More large trials needed to decide best duration of treatment with tamoxifen. BMJ (1998) 0.75
Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer. Breast Care (Basel) (2017) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol (1996) 4.92
Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet (2000) 4.39
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol (1995) 3.51
Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG (2007) 3.31
HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS (2001) 3.30
Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol (2000) 3.10
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med (1990) 2.75
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand (2009) 2.68
Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health (1998) 2.53
The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation (1993) 2.51
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol (1999) 2.22
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
Large-scale randomized evidence: large, simple trials and overviews of trials. Ann N Y Acad Sci (1993) 2.08
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer. J Clin Oncol (1992) 2.02
National study of colorectal cancer genetics. Br J Cancer (2007) 1.92
Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res (1991) 1.92
Vitamin D metabolism: the role of kidney tissue. Science (1971) 1.91
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol (1991) 1.91
Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry (2001) 1.75
Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care (2004) 1.74
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med (1989) 1.70
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. Lancet Neurol (2008) 1.62
Noradrenaline and beta-adrenoceptor agonists increase activity of voltage-dependent calcium channels in hippocampal neurons. Nature (1987) 1.62
Cost-efficient study designs for binary response data with Gaussian covariate measurement error. Biometrics (1991) 1.59
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J (1975) 1.58
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Pyridine nucleotides in cancer. Lancet (1965) 1.56
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. J Clin Oncol (1993) 1.55
Anomalies of the inferior vena cava. AJR Am J Roentgenol (1983) 1.52
Neurocognitive consequences of marihuana--a comparison with pre-drug performance. Neurotoxicol Teratol (2004) 1.51
Safer non-cardiac surgery for patients with coronary artery disease. Medical treatment should be optimised to improve outcome. BMJ (1998) 1.51
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Report of the Working Party of the Endoscopy Committee of the British Society of Gastroenterology on the reuse of endoscopic accessories. Gut (1998) 1.44
Unexpected toxicity in patients treated with iphosphamide. Cancer Res (1972) 1.44
Glucose production by the human placenta in vivo. Placenta (1999) 1.42
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol (2000) 1.42
Construction of receiver operating characteristic curves when disease verification is subject to selection bias. Med Decis Making (1984) 1.41
Properties and distribution of single voltage-gated calcium channels in adult hippocampal neurons. J Neurophysiol (1990) 1.41
NMDA-receptor-independent long-term potentiation. Annu Rev Physiol (1992) 1.41
Tamoxifen: how boldly to go where no women have gone before. J Natl Cancer Inst (1993) 1.40
Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol (1998) 1.37
Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann N Y Acad Sci (1999) 1.36
Experiences with maternal and perinatal death reviews in the UK--the MBRRACE-UK programme. BJOG (2014) 1.36
A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol (1993) 1.34
Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med (1987) 1.28
Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev (2008) 1.28
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol (2001) 1.26
Rectification of single GABA-gated chloride channels in adult hippocampal neurons. J Neurophysiol (1985) 1.26
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med (1989) 1.23
Guidelines for drug donations. BMJ (1997) 1.23
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study. J Clin Oncol (1998) 1.21
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab (2001) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Patient-health care provider communication during chemotherapy treatment: the perspectives of women with breast cancer. Patient Educ Couns (2001) 1.17
Adjuvant therapy for cancer of the colon. BMJ (1991) 1.17
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives. Contraception (1984) 1.16
L-Type calcium channels are required for one form of hippocampal mossy fiber LTP. J Neurophysiol (1998) 1.16
Prognostic factors for survival in hepatocellular carcinoma. Cancer Res (1988) 1.16
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer. Ann Oncol (1996) 1.15
Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. J Clin Oncol (1993) 1.14
Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess (2011) 1.13
Drifting vortices of electrical waves underlie ventricular fibrillation in the rabbit heart. Acta Physiol Scand (1996) 1.12
Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol (1994) 1.11
Do nurses or doctors have an increased risk of developing multiple sclerosis? J Neurol Neurosurg Psychiatry (1990) 1.11
Inflammation in osteoarthritis. Clin Rheum Dis (1985) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Tamoxifen for early breast cancer: better late than never. Ann Oncol (2000) 1.10
Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer. Ann Oncol (2005) 1.09
Absolute measurement of hadronic branching fractions of the Ds+ meson. Phys Rev Lett (2008) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res (1991) 1.08
Partial agonists and suicide: the role of the mental health nurse. J Psychiatr Ment Health Nurs (2008) 1.08
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer. J Natl Cancer Inst (1995) 1.08
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom. Clin Oncol (R Coll Radiol) (1997) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
N-methyl-D-aspartate receptor activation increases cAMP levels and voltage-gated Ca2+ channel activity in area CA1 of hippocampus. Proc Natl Acad Sci U S A (1991) 1.08
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol (1991) 1.07